Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2019 4
2020 4
2021 11
2022 7
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Expression of Novel Kinase MAP3K19 in Various Cancers and Survival Correlations.
Nguyen K, Yousefi H, Cheng T, Magrath J, Hartono AB, Alzoubi M, Hebert K, Brock CK, Wright MK, Byrne CE, Rivera A, Okpechi SC, Matossian MD, Wathieu H, Elliott S, Mondrinos MJ, Lee SB, Collins-Burow BM, Alahari SK, Drewry DH, Burow ME. Nguyen K, et al. Among authors: matossian md. Front Biosci (Landmark Ed). 2022 Jun 17;27(6):196. doi: 10.31083/j.fbl2706196. Front Biosci (Landmark Ed). 2022. PMID: 35748272 Free article. Review.
ERAS implementation in an urban patient population undergoing gynecologic surgery.
Brown ML, Simpson V, Clark AB, Matossian MD, Holman SL, Jernigan AM, Scheib SA, Shank J, Key A, Chapple AG, Kelly E, Nair N. Brown ML, et al. Among authors: matossian md. Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):1-11. doi: 10.1016/j.bpobgyn.2022.07.009. Epub 2022 Aug 7. Best Pract Res Clin Obstet Gynaecol. 2022. PMID: 36031533 Review.
Patient-Derived Xenografts as an Innovative Surrogate Tumor Model for the Investigation of Health Disparities in Triple Negative Breast Cancer.
Matossian MD, Giardina AA, Wright MK, Elliott S, Loch MM, Nguyen K, Zea AH, Lau FH, Moroz K, Riker AI, Jones SD, Martin EC, Bunnell BA, Miele L, Collins-Burow BM, Burow ME. Matossian MD, et al. Womens Health Rep (New Rochelle). 2020 Sep 24;1(1):383-392. doi: 10.1089/whr.2020.0037. eCollection 2020. Womens Health Rep (New Rochelle). 2020. PMID: 33786503 Free PMC article. Review.
Ceritinib is a novel triple negative breast cancer therapeutic agent.
Dong S, Yousefi H, Savage IV, Okpechi SC, Wright MK, Matossian MD, Collins-Burow BM, Burow ME, Alahari SK. Dong S, et al. Among authors: matossian md. Mol Cancer. 2022 Jun 29;21(1):138. doi: 10.1186/s12943-022-01601-0. Mol Cancer. 2022. PMID: 35768871 Free PMC article.
29 results